Recent evidence suggests that therapy currently used to treat Helicobacter pylori (H. pylori) infection, a major cause of upper gastrointestinal disorders , is unsuccessful in around 25 percent of cases.

A new study, published in The American Journal of Gastroenterology, finds that adding a bovine protein called lactoferrin to the existing treatment may yield more effective results, with fewer of the side effects associated with common antibiotic treatment.

Lactoferrin has previously been found to be effective at inhibiting the growth of microorganisms and reducing the side effects of antibiotics, respectively, but the new study marks the first time that they have been used together to treat H. pylori.

The study found that the infection-causing bacterium was eliminated in more patients treated with the traditional therapy plus lactoferrin than with the existing treatments and may be used without risk of resistance.

Various studies are under way to evaluate new antibiotics and different therapeutic methods to increase the efficacy of H. pylori therapy, says lead author Nicola de Bortoli, M.D., Ph.D., adding that data suggest that antibiotic resistance is frequent and clinicians are realizing that use of an additional agent may be necessary for therapy.


'"/>




Page: 1
Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres